TSHA Taysha Gene Therapies, Inc.
$5.40▲ +0.75%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$1.55B
P/E Ratio
–
Div Yield
–%
52W Range
2.25 - 7.30
% vs 50 MA
-6.91%
% vs 200 MA
12.13%
RSI-14
41.4
MACD Histogram
-0.0600
Beta (1Y vs SPY)
2.07
Free Cash Flow
-$26.97M
Gross Rev
$5.49M
Gross Profit
$5.49M
EBITDA
-$26.80M
COGS
–
Operating Exp
$33.79M
Operating Income
-$28.30M
EBIT
-$28.30M
Pretax Income
-$27.85M
Net Income
-$27.85M
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Dec 2025 (Quarterly)
Social Sentiment
No Reddit posts found for TSHA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.